Florida Medical Pain Management is one of the largest and most established pain management facilities in the Bay Area. We offer a comprehensive approach to pain management in hopes of alleviating our patients’ pain with the latest medical knowledge and technology.
All of our physicians have been fellowship trained in Interventional Pain Management to ensure the highest quality of care for our patients. The goals of interventional pain management are to relieve, reduce, or manage pain and improve a patient’s overall quality of life through minimally invasive procedures and techniques specifically designed to diagnose and treat painful conditions. Our goal is to further improve the quality of life by minimizing the need for narcotics.
Kazi Hassan, M.D.
Kazi Hassan, M.D. is board certified, specializing in Anesthesiology with a sub-specialty in Interventional Pain Management, by the American Board of Anesthesiology. He completed his undergraduate education at the University of New York, Buffalo. He then returned to his home country to complete his degree as a Medical Doctor in Bangladesh at the University of Dhaka. He returned to the US where he completed a surgical residency at St. Francis Hospital, in New Jersey. He completed a residency in anesthesiology at St. Joseph’s Hospital in New Jersey. He continued his education at St. Luke’s Roosevelt Hospital, Columbia University College of Physicians and Surgeons in New York by completing a fellowship in Interventional Pain Management.
Dr. Hassan practiced both anesthesia and pain management briefly in Clearwater before opening his practice in St. Petersburg. He is currently the Medical Director of Florida Medical Pain Management. He also holds professional membership in the American Society of Anesthesiologists, Florida Society of Anesthesiologists, and the American Academy of Pain Management.
- 1. Study of the Efficacy and Safety of XXXX in Subjects with Opioid-induced Bowel Dysfunction
- 2. Study With an Open-label Run-in to Assess the Efficacy and Safety of XXXX tablets 20 to 120 mg Once-daily in Subjects with moderate to Severe Chronic Low Back Pain
- 3. Study to Evaluate Effectiveness and Safety of a XXXX for the Treatment of Osteoarthritis of the Knee with Open Label Safety Extension
- 4. Study of XXXX in Patients with Lumbar Disc Herniation
- 5. Study of XXXX in Patients with Lumbar Disc Herniation (Phase III)
- 6. Trial Investigating the Efficacy and Safety of Intravenous XXXX in Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)
- 7. A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
- 8. Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-Dose Long-Term Opioid Analgesic Therapy For Chronic Pain
- 9. Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-Dose, Long-Term Opioid Analgesic Therapy for Chronic Pain as Measured by Quantitative Sensory Testing
- 10. Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects with a Recent History of Moderate to Severe Chronic Low Back Pain Currently Treated with Opioids
- 11. Study Comparing the Efficacy and Safety of 2 Dose-Regimens of TEV-48125 (1 Intravenous Administration, and 1 subcutaneous) Versus Placebo for the PreventionofChronic Cluster Headache (CCH)
- 12. Study Comparing the Efficacy and Safety of 2 Dose-Regimens of TEV-48125 ( 1 Intravenous Administration, and 1 subcutaneous) Versus Placebo for the Prevention of Episodic Cluster Headache (ECH)
- 13. Study to Explore the Long-Term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Prevention of Cluster Headache (LTSCH)